Correlation between self-reported adherence to highly active antiretroviral therapy (HAART) and virologic outcome

• Published in: Advances in therapy Vol. 18; no. 4; pp. 163 - 173
• Main Authors: DeMasi, Ralph A., Graham, Neil M., Tolson, Jerry M., Pham, Sissi V., Capuano, George A., Fisher, Robin L., Shaefer, Mark S., Pakes, Gary E., Sawyerr, Gosford A., Eron, Joseph J.
• Format: Journal Article
• Language: English
• Published: Edison, NJ Health Communications 01.07.2001
• Subjects: Adolescent; Adult; AIDS Serodiagnosis; Anti-HIV Agents - administration & dosage; Antibiotics. Antiinfectious agents. Antiparasitic agents; Antiviral agents; Biological and medical sciences; Drug Administration Schedule; Drug Combinations; Female; HIV Infections - diagnosis; HIV Infections - drug therapy; HIV-1 - isolation & purification; Human immunodeficiency virus 1; Humans; Lamivudine - administration & dosage; Logistic Models; Male; Medical sciences; Middle Aged; Patient Compliance - statistics & numerical data; Patient Participation; Pharmacology. Drug treatments; Prospective Studies; RNA, Viral - analysis; Surveys and Questionnaires; Treatment Refusal - statistics & numerical data; Viral Load; Zidovudine - administration & dosage; Questionnaire; RNA-directed DNA polymerase; HIV-1 virus; Self evaluation; Drug compliance; Reverse transcriptase inhibitor; Antiviral; Viral load; Pyrimidine nucleoside; Human; Drug combination; Enzyme; Transferases; Retroviridae; Enzyme inhibitor; Lamivudine; Lentivirus; Infection; Virus; Nucleotidyltransferases; Chemotherapy; Treatment; Dideoxynucleoside; Viral disease; Human immunodeficiency virus; Zidovudine; Protease inhibitor

The Patient Medication Adherence Questionnaire Version 1.0 (PMAQ-V1.0) is a patient-reported adherence instrument to assess medication-taking behaviors and identify barriers to adherence with antiretroviral therapy. To assess the correlation between adherence and virologic outcome, the PMAQ-V1.0 was...